Skip to content
PatientMatchFind trials

Screener

Eligibility screening

SynKIR-310 for Relapsed/Refractory B-NHL

Sponsored by Verismo TherapeuticsStudy detailsClinicalTrials.gov

5 US sites in CO, GA, KS, NJ +1

Before we begin

Who are you filling this out for?

Your answer affects how the questions are phrased.